Vani Pharma Labs Limited, a active public limited company, was established on 15 June 1976 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24110TG1976PLC002040. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.40 Cr and a paid-up capital of ₹2.65 Cr.
Formerly known as Vani Chemicals & Intermediates Limited, Vani Chemicals & Intermediates P Ltd. It upholds a compliant status. Its leadership includes Chakradhar Mallampati (Managing Director), Kalyan Gadde (Director), Lakshmi Kranthi Mallampati (Additional Director). Past directors included Medempudi Ranga Rao, Sreehari Kumar Annamraju, Mallikharjun Rao Yalavarthi. It holds ₹48.80 Cr open charges and ₹15.34 Cr settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Plot No. 11, Industrial Development Area Ida Jeedimetla, Hyderabad, Telangana, 500055.
U24110TG1976PLC002040
002040
15 June 1976
₹4.40 Cr
₹2.65 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Vani Pharma Labs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chakradhar Mallampati | Managing Director | 22 Dec 1998 | Current |
| Kalyan Gadde | Director | 22 Dec 2017 | Current |
| Lakshmi Kranthi Mallampati | Additional Director | 24 Dec 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 21 Sep 2008 | Past |
| Pramod Abcsdd | Additional Director | 04 Oct 2023 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Jun 2011 | Past |
| Pramod Abcsdd | Director | 24 Dec 2021 | Past |
| Pramod Abcsdd | Whole-Time Director | 07 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 04 Oct 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vani Pharma Labs Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 40.44% increase. The company also saw a substantial improvement in profitability, with a 61.3% increase in profit. The company's net worth Soared by an impressive increase of 78.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Vani Pharma Labs had a promoter holding of 46.31% and a public holding of 53.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹488,009,715.38
₹153,397,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2022 | Standard Chartered Bank | ₹5.00 Cr | Open |
| 11 May 2022 | Axis Bank Limited | ₹7.50 Cr | Open |
| 12 Nov 2020 | Others | ₹2.52 Cr | Open |
| 26 Jun 2020 | Others | ₹19.26 Cr | Open |
| 23 Nov 2018 | State Bank Of India | ₹14.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vani Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vani Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vani Pharma Labs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Standard Chartered Bank amounted to Rs. 5.00 Cr with Charge ID 100581050 was registered on 09 Jun 2022. was documented.
A charge with Axis Bank Limited amounted to Rs. 7.50 Cr with Charge ID 100579224 was registered on 11 May 2022. was recorded as a recent event.
Progress on Lakshmi Kranthi Mallampati was appointed as a Additional Director was appointed as a Additional Director on 24 Dec 2021 & has been associated with this company since 3 years 11 months . was documented.
The activity A charge with Others of Rs. 19.26 Cr registered on 26 Jun 2020 with Charge ID 100358673 was modified on 29 Apr 2021. was completed.
The activity Vani Pharma Labs Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.
Progress on A charge with Others amounted to Rs. 2.52 Cr with Charge ID 100389650 was registered on 12 Nov 2020. was documented.
The CIN of Vani Pharma Labs Limited is U24110TG1976PLC002040.
Vani Pharma Labs Limited is headquartered at Plot No. 11, Industrial Development Area Ida Jeedimetla, Hyderabad, Telangana, 500055.
Vani Pharma Labs Limited was incorporated on 15 June 1976.
The current directors of Vani Pharma Labs Limited are
The primary industry of Vani Pharma Labs Limited is Manufacturing.
Vani Pharma Labs Limited is unlisted.
The authorized capital of Vani Pharma Labs Limited is ₹4.40 Cr, and the paid-up capital is ₹2.65 Cr.
The compliance status of Vani Pharma Labs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX